Daybue was turned down for Rett syndrome, and Iloperidone for schizophrenia and bipolar I, with safety and benefit-risk concerns cited in both cases.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/ema-rejects-drugs-rett-syndrome-schizophrenia-2026a100068m?src=rss
Author :
Publish date : 2026-02-27 16:28:00
Copyright for syndicated content belongs to the linked Source.